Literature DB >> 25911586

Soluble Syndecan-1: Does This Biomarker Address a Seemingly Insoluble Problem in Inflammatory Bowel Disease?

Angela M Patterson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25911586     DOI： 10.1007/s10620-015-3669-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  12 in total

1.  Monitoring inflammatory bowel disease activity: clinical activity is judged to be more relevant than endoscopic severity or biomarkers.

Authors:  Alain M Schoepfer; Stephan Vavricka; Nadine Zahnd-Straumann; Alex Straumann; Christoph Beglinger
Journal:  J Crohns Colitis       Date:  2011-10-14       Impact factor: 9.071

Review 2.  Proteoglycans in health and disease: the multiple roles of syndecan shedding.

Authors:  Tina Manon-Jensen; Yoshifumi Itoh; John R Couchman
Journal:  FEBS J       Date:  2010-08-31       Impact factor: 5.542

Review 3.  Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers?

Authors:  D S Pardi; W J Sandborn
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

4.  Do changes in intestinal permeability predict disease relapse in Crohn's disease?

Authors:  H Vogelsang
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

Review 5.  Laboratory markers in ulcerative colitis: Current insights and future advances.

Authors:  Michele Cioffi; Antonella De Rosa; Rosalba Serao; Ilaria Picone; Maria Teresa Vietri
Journal:  World J Gastrointest Pathophysiol       Date:  2015-02-15

6.  Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel Disease.

Authors:  Doron Yablecovitch; Assaf Stein; Maytal Shabat-Simon; Timna Naftali; Gila Gabay; Ido Laish; Asaf Oren; Fred M Konikoff
Journal:  Dig Dis Sci       Date:  2015-02-22       Impact factor: 3.199

Review 7.  Heparan sulfate proteoglycans.

Authors:  Stephane Sarrazin; William C Lamanna; Jeffrey D Esko
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

8.  Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function.

Authors:  Lars Bode; Camilla Salvestrini; Pyong Woo Park; Jin-Ping Li; Jeffrey D Esko; Yu Yamaguchi; Simon Murch; Hudson H Freeze
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 9.  Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.

Authors:  Tue Bennike; Svend Birkelund; Allan Stensballe; Vibeke Andersen
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

Review 10.  Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases.

Authors:  Sung Hee Lee
Journal:  Intest Res       Date:  2015-01-29
View more
  3 in total

Review 1.  Targeting syndecan-1: new opportunities in cancer therapy.

Authors:  Zecheng Yang; Shuaitong Chen; Haoqiang Ying; Wantong Yao
Journal:  Am J Physiol Cell Physiol       Date:  2022-05-18       Impact factor: 5.282

2.  Altered Distribution and Expression of Syndecan-1 and -4 as an Additional Hallmark in Psoriasis.

Authors:  Eleni Koliakou; Manthou Maria Eleni; Ioanna Koumentakou; Nikolaos Bikiaris; Polyanthi Konstantinidou; Patricia Rousselle; Doxakis Anestakis; Elisabeth Lazaridou; Evangelia Kalloniati; Miliaras Dimosthenis; Anna Michopoulou
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

Review 3.  Syndecans in Inflammation at a Glance.

Authors:  Sandeep Gopal
Journal:  Front Immunol       Date:  2020-02-18       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.